Our firm has focused on pharma/bio/chemical IP cases ever since its establishment in February 2006. As inventions of this field encompass complicated technical concepts and various cutting-edge technologies, only specialists in this field could understand such complex inventions and represent the same before the Korean Intellectual Property Office (KIPO) and the Patent Court.
Patent trials and litigations are the highest arena of expertise where extensive technical and legal knowledge and accumulated litigation experience are essential.
Our firm provides patent strategy for every stage of IP management, from the R&D planning stage to the patent acquisition and enforcement stage. Some examples of such strategies include technology trend analysis through patent mapping, design around, patent portfolio establishment, pre-review of patent infringement, and monitoring of patents covering competitor’s product.
“IBRANCE TAB" Patent Case: Scope Confirmation
Represented Shin Poong Pharm
“DUKARB” Patent Case: Invalidation
Represented patentee Boryung Pharm
“DUKARB” Patent Case: Scope Confirmation
Represented patentee Boryung Pharm
“OPSUMIT” Patent Case: Scope Confirmation"
Represented Samjin Pharm
“VEMLIDY” Patent Case: Scope Confirmation
Represented 4 Korean pharmaceutical companies including Samjin Pharm
“ESODUO” Composition Patent Case: Invalidation
Represented patentee Chong Kun Dang Pharm
“FORXIGA” Formulation Patent Case: Invalidation
Represented 4 Korean pharmaceutical companies including KyungDong Pharm
“IBRANCE” Patent Case: Scope Confirmation
Represented Shin Poong Pharm
“VORTIOXETINE” Patent Case: Scope Confirmation / Invalidation
Represented Whan In Pharm
ESODUO” Patent Case: Invalidation
Represented patentee Chong Kun Dang Pharm
“PERAMIFLU INJ.” Patent Case: Invalidation
Represented HK inno.N
“VEMLIDY” Patent Case: Scope Confirmation
Represented Chong Kun Dang Pharm and Daewoong Pharm
“BELKYRA (formulation 4)” Patent Case: Scope Confirmation
Represented PENMIX
“BELKYRA (formulation 3)” Patent Case: Scope Confirmation
Represented PENMIX
“BELKYRA (formulation 2)” Patent Case: Scope Confirmation
Represented PENMIX
“SIMBRINZA” Patent Case: Scope Confirmation
Represented Taejoon Pharm
“TENELIA M SR” Formulation Patent Case: Scope Confirmation
Represented KyungDong Pharm and Genuone Sciences
“XARELTO” Patent Case: Scope Confirmation
Represented Samjin Pharm
“JARDIANCE” Patent Case: Scope Confirmation
Represented Kukje Pharm
“NESP” Patent Case: Invalidation
Represented Dong-A ST
“BELKYRA (formulation 1)” Patent Case: Scope Confirmation
Represented PENMIX
“OLOSTAR” Patent Case: Scope Confirmation
Represented 12 Korean pharmaceutical companies including Kolmar Korea
“LIXIANA” Patent Case: Scope Confirmation
Represented 6 Korean pharmaceutical companies including HK inno.N
“TENELIGLIPTIN” Salt Patent Case: Scope Confirmation
Represented KyungDong Pharm
“CERTICAN” Patent Case: Scope Confirmation
Represented Chong Kun Dang Pharm
“CILOSTA” Patent Case: Scope Confirmation
Represented KyungDong Pharm
“GLEEVEC” Use Patent Case: Invalidation
Represented Boryung Pharm and Jeil Pharm
“SILK PEPTIDE” Patent Case: Invalidation
Represented Famenity
“FORXIGA” Crystal Patent Case: Scope Confirmation
Represented 4 Korean pharmaceutical companies including KyungDong Pharm
“XELJANZ TAB” Patent Case: Invalidation/ Scope Confirmation
Represented 6 Korean pharmaceutical companies including Yuhan Corp
“SITAGLIPTIN” Phosphate and Phosphate Monohydrate Patent Case..
Represented 10 Korean pharmaceutical companies including Dasan Pharm and Chong Kun Dang Pharm
“ALITON” Patent Case: Scope Confirmation
Represented Kolmar Korea and Kolmar Pharma
“RITUXAN” Use Patent Case: Invalidation/ Scope Confirmation
Represented Celltrion Pharm
“TRAJENTA TAB” Formulation Patent Case: Scope Confirmation
Represented 4 Korean pharmaceutical companies including KyungDong Pharm
“ACTOSRYL / ACTOSMET” Patent Case: Scope Confirmation
Represented 7 Korean pharmaceutical companies including HK inno.N
“EPO” Composition Patent Case: Invalidation
Represented TS Corp
“TRAJENTA TAB” Crystal Patent Case: Invalidation
Represented 4 Korean pharmaceutical companies including Daewon Pharm
“VIGAMOX” Patent Case: Invalidation
Represented 5 Korean pharmaceutical companies including Sam Chun Dang Pharm
“FEBUXOSTAT” Patent Case: Scope Confirmation
Represented Korea United Pharm
“FORXIGA” Formulation Patent Case: Invalidation / Scope Confi..
Represented 6 Korean pharmaceutical companies including KyungDong Pharm
“BRILINTA” Patent Case: Scope Confirmation
Represented 7 Korean pharmaceutical companies including CJ Corp
“THRUPAS” Patent Case: Scope Confirmation
Represented Chong Kun Dang Pharm
“VIREAD” Salt Patent Case: Scope Confirmation
Represented 9 Korean pharmaceutical companies including Samjin Pharm
“BARACLUDE” Patent Case: Scope Confirmation
Represented Jeil Pharm
“VIAGRA” Patent Case: Invalidation
Represented Samjin Pharm
“KREMEZIN” Patent Case: Invalidation
Represented Daewon Pharm
“GLEEVEC” Formulation Patent Case: Invalidation
Represented Boryung Pharm
“DIVALTAN” Trademark Case: Non-use cancellation
Represented Shin Poong Pharm
“EPO” Patent Case: Scope Confirmation
Represented TS Corp
Thrombolytic Combination Patent Case: Invalidation / Scope Confir..
Represented CJ Corp
“DIOTEN” Trademark Case: Invalidation
Represented Samil Pharm
“TAXOTERE” Patent Case: Invalidation / Scope Confirmation
Represented Boryung Pharm
“ZANEDIP” Patent Case: Invalidation
Represented Celltrion Pharm
Multifunctional Chalkboard Patent Case: Invalidation/ Scope Confi..
Represented Korea Biochalk
“EVISTA” Patent Case: Invalidation/ Scope Confirmation
Represented KyungDong Pharm
“LIPITOR” Patent Case: Invalidation
Represented 10 Korean pharmaceutical companies including CJ Corp. and Dong-A Pharm
“NORVASC” Patent Case: Invalidation / Scope Confirmation
Represented Kukje Pharm
“PLAVIX” Patent Case: Invalidation
Represented 10 Korean pharmaceutical companies including CJ Corp
“ELOXATIN” Patent Case: Invalidation
Represented Boryung Pharm
“GEMZAR”: Investigation of unfair trade practices by Trade Co..
Represented Shin Poong Pharm and Yuhan Corp
“ARIMIDEX” Patent Case: Invalidation
Represented Boryung Pharm
“ULTRACET” Patent Case: Invalidation
Represented Samjin Pharm
“COZAAR PLUS” Patent Case: Invalidation / Active Scope Confir..
Represented KyungDong Pharm
Lens Composition Patent Case: Invalidation / Scope Confirmation
Represented Doosan Corp. and Chang Woo
“EPO” Patent Case: Invalidation / Scope Confirmation
Represented CJ Corp
“G-CSF” Patent Case: Invalidation
Represented CJ Corp
Choco Mochi Cake Patent Case: Invalidation
Represented Samjin CNF
3F, 416, Nonhyeon-ro, Gangnam-gu, Seoul, Korea
06224
E. pat@ahnpatent.co.kr
T. +82-2-558-3222F. +82-2-558-3246
Copyrightⓒ2006 Dr.Ahn. All Rights Reserved.